Synapse - Works

Results (13087)

Single-agent bortezomib in previously untreated multiple myeloma (MM): Results of a phase II multicenter study

Meeting Abstract

Anderson, K.; Richardson, P.; Chanan-Khan, A.; Schlossman, R.; Munshi, N.; Oaklander, A.; Heffner, L.; Hassoun, H.; Avigan, D.; Amato, A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Peripheral T cell apoptosis is associated with homeostatic T cell proliferation and plays a significant role in post-transplant immune deficiency

Meeting Abstract

Alpdogan, O.; Patel, N.; Suh, D.; Grubin, J.; McGoldrick, S.; Smith, O. M.; Lu, S.; King, C.; Kochman, A.; Hubbard, V.; more...
Blood (2006)

Fulltext@MSK | Save

Peripheral T cell apoptosis affects immune reconstitution after allogeneic BMT

Meeting Abstract

Alpdogan, O.; McGoldrick, S.; Lu, S.; Patel, N.; Suh, D.; Smith, O. M.; van den Brink, M. R. M.
Biology of Blood and Marrow Transplantation (2006)

Fulltext@MSK | Save

A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT)

Journal Article

Ng, J.; Rogosheske, J.; Barker, J.; Weisdorf, D.; Jacobson, P. A.
Therapeutic Drug Monitoring (2006)

Fulltext@MSK | Save

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

Journal Article

Heidel, F.; Solem, F. K.; Breitenbuecher, F.; Lipka, D. B.; Kasper, S.; Thiede, M. H.; Brandts, C.; Serve, H.; Roesel, J.; Giles, F.; more...
Blood (2006)

Fulltext@MSK | Save

Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: Safety, pharmacokinetics, and pharmacodynamics